These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31230676)

  • 1. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Selvaraj S; Jauhar S; Baldwin DS; Cowen PJ; Goodwin G; Hayes JF; Nutt DJ; Veronese M; Young AH
    Lancet Psychiatry; 2019 Jul; 6(7):560-561. PubMed ID: 31230676
    [No Abstract]   [Full Text] [Related]  

  • 2. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Kronenberg G; Desai D; Anghelescu I
    Lancet Psychiatry; 2019 Jul; 6(7):560. PubMed ID: 31230675
    [No Abstract]   [Full Text] [Related]  

  • 3. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Ruhe HG; Horikx A; van Avendonk MJP; Groeneweg BF; Woutersen-Koch H;
    Lancet Psychiatry; 2019 Jul; 6(7):561-562. PubMed ID: 31230677
    [No Abstract]   [Full Text] [Related]  

  • 4. Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply.
    Horowitz MA; Taylor D
    Lancet Psychiatry; 2019 Jul; 6(7):562-563. PubMed ID: 31230678
    [No Abstract]   [Full Text] [Related]  

  • 5. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Horowitz MA; Taylor D
    Lancet Psychiatry; 2019 Jun; 6(6):538-546. PubMed ID: 30850328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor 'discontinuation syndrome' or withdrawal.
    Massabki I; Abi-Jaoude E
    Br J Psychiatry; 2021 Mar; 218(3):168-171. PubMed ID: 31902371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
    Beurmanjer H; Luykx JJ; De Wilde B; van Rompaey K; Buwalda VJA; De Jong CAJ; Dijkstra BAG; Schellekens AFA
    CNS Drugs; 2020 Jun; 34(6):651-659. PubMed ID: 32319006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRI and SNRI withdrawal symptoms reported on an internet forum.
    Stockmann T; Odegbaro D; Timimi S; Moncrieff J
    Int J Risk Saf Med; 2018; 29(3-4):175-180. PubMed ID: 29758951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program.
    Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL
    Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of mood disorders and treatment discontinuation.
    Lader M
    Drugs; 2007; 67(12):1657-63. PubMed ID: 17683167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic Drug Withdrawal and Holistic Tapering Strategies: A Case Series.
    Brogan K; Siefert A; Whitson E; Kirsh L; Sweetan V
    Adv Mind Body Med; 2019 Fall; 33(4):4-16. PubMed ID: 32738037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature ejaculation associated with citalopram withdrawal.
    Adson DE; Kotlyar M
    Ann Pharmacother; 2003 Dec; 37(12):1804-6. PubMed ID: 14632589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing withdrawal symptoms using tapering strips.
    Groot PC; van Os J
    Br J Gen Pract; 2023 May; 73(730):203-204. PubMed ID: 37105754
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor discontinuation syndrome: a review.
    Tamam L; Ozpoyraz N
    Adv Ther; 2002; 19(1):17-26. PubMed ID: 12008858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of non-opioid interventions to reduce opioid withdrawal symptoms in patients with chronic pain: a systematic review.
    Langejan AI; de Kleijn L; Rijkels-Otters HJBM; Chudy SFJ; Chiarotto A; Koes BW
    Fam Pract; 2022 Mar; 39(2):295-300. PubMed ID: 34849764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
    J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.